» Articles » PMID: 35575295

Association Between Cytokine Concentration Kinetics and Prolonged Fever in Febrile Neutropenic Children with Bacteremia

Overview
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: Although prolonged fever in patients with neutropenic fever (NF) during empirical antibiotic therapy could be caused by dysregulated immune responses, its association with cytokine concentrations has rarely been investigated. This study determined the kinetics of cytokine concentrations in pediatric patients with NF and bacteremia and evaluated the impact of cytokine concentration kinetics on prolonged fever.

Methods: Concentrations of 13 cytokines were measured on the initial day of NF (Day 1) and 3 days (Day 4) and 7 days (Day 8) later in 10 patients with NF with bacteremia, and their kinetics was determined. The results for each cytokine concentration on each sampling day were compared for patients with fever that lasted ⩾3 days and those with fever that lasted <3 days.

Results: Interleukin (IL)-6 ( < .001) and IL-10 ( = .001) concentrations were significantly higher on Day 1 than on Days 4 and 8. However, the increased IL-6 ( = 1.000) and IL-10 ( = 1.000) concentrations on Day 1 were not associated with prolonged fever (⩾3 days). For other cytokines, the concentrations measured on Days 1, 4, and 8 were similar regardless of fever duration.

Conclusion: Prolonged fever in patients with NF and bacteremia was not associated with a prolonged increase in a specific cytokine concentration.

References
1.
Haeusler G, Carlesse F, Phillips R . An updated systematic review and meta-analysis of the predictive value of serum biomarkers in the assessment of fever during neutropenia in children with cancer. Pediatr Infect Dis J. 2013; 32(10):e390-6. DOI: 10.1097/INF.0b013e31829ae38d. View

2.
Richter M, Neugebauer S, Engelmann F, Hagel S, Ludewig K, La Rosee P . Biomarker candidates for the detection of an infectious etiology of febrile neutropenia. Infection. 2015; 44(2):175-86. DOI: 10.1007/s15010-015-0830-6. View

3.
Freifeld A, Bow E, Sepkowitz K, Boeckh M, Ito J, Mullen C . Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the infectious diseases society of america. Clin Infect Dis. 2011; 52(4):e56-93. DOI: 10.1093/cid/cir073. View

4.
Lee D, Kim S, Kim S, Kim C, Beom Park W, Song Y . Evidence-based guidelines for empirical therapy of neutropenic fever in Korea. Korean J Intern Med. 2011; 26(2):220-52. PMC: 3110859. DOI: 10.3904/kjim.2011.26.2.220. View

5.
Kitanovski L, Jazbec J, Hojker S, Gubina M, Derganc M . Diagnostic accuracy of procalcitonin and interleukin-6 values for predicting bacteremia and clinical sepsis in febrile neutropenic children with cancer. Eur J Clin Microbiol Infect Dis. 2006; 25(6):413-5. DOI: 10.1007/s10096-006-0143-x. View